EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Progress in the Treatment of Ulcerative Colitis by Targeting NLRP3 Inflammasome

Jiaying Chen iD, Erxin Zhang iD, Xuantao Qian, Xiaoqing Shang, Jie Yu, Jiheng Luo, Weiwei Hao

Drug Design, Development and Therapy · 2026-06 · Volume 20 · 1-17

DOI: 10.2147/dddt.s611506 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-06. Verfasst von Jiaying Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of C…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Colitis, Ulcerative, Inflammasomes. Die Arbeit nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinColitis, UlcerativeInflammasomesHumansAnimals

Stichwörter der Autor:innen

NLRP3NLRP3 inhibitorsinflammatory bowel diseaseulcerative colitis

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesNLRP3 protein, human

Autor:innen und Institutionen

  • Department of Gastroenterology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
  • Department of Traditional Chinese Medicine, Shanghai Pudong New District Huamu Community Health Service Center, Shanghai, People's Republic of China.

ORCID-Profile: Jiaying Chen, Erxin Zhang

Zitieren

APA

Chen, J., Zhang, E., Qian, X., Shang, X., Yu, J., Luo, J., & Hao, W. (2026). Progress in the Treatment of Ulcerative Colitis by Targeting NLRP3 Inflammasome. Drug Design, Development and Therapy, Volume 20, 1-17. https://doi.org/10.2147/dddt.s611506

Vancouver

Chen J, Zhang E, Qian X, Shang X, Yu J, Luo J, et al. Progress in the Treatment of Ulcerative Colitis by Targeting NLRP3 Inflammasome. Drug Design, Development and Therapy. 2026;Volume 20:1-17. doi:10.2147/dddt.s611506

BibTeX
@article{Chen2026,
  author = {Chen, Jiaying and Zhang, Erxin and Qian, Xuantao and Shang, Xiaoqing and Yu, Jie and Luo, Jiheng and Hao, Weiwei},
  title = {Progress in the Treatment of Ulcerative Colitis by Targeting NLRP3 Inflammasome},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--17},
  doi = {10.2147/dddt.s611506}
}
Kostenlos starten →